Stimulus money was only a short-term fix as rural hospitals brace for the next COVID-19 surges

One by one, COVID-19 outbreaks popped up in April and May at meatpacking plants across the country, fanning fears that the infectious coronavirus could spread rapidly into rural states. Plants closed temporarily in small metro areas like Waterloo, and Sioux Falls, South Dakota, but also smaller Iowa towns like Tama, Columbus Junction and Perry. 

Leaders at Buena Vista Regional Medical Center in Storm Lake, a northwest Iowa town of 10,500 with a Tyson Foods packing plant, knew their time would come. “We just didn’t know to what degree,” Rob Colerick, the hospital CEO and administrator, said. “I mean, you saw it in Columbus Junction. You saw it in Waterloo.

COVID-19 scuttles jobs, internships for Iowa’s college students

Paige Marsh went through five interviews before getting a job offer from a national insurance company, headquartered in Des Moines, back in January. “I have been in touch with the company every month since I signed my offer letter,” Marsh, a senior business administration major at Wartburg College,  said. “And then I just got the call about the company freezing all new hires until 2021.”

She will continue to search for work in the meantime. College students, like Marsh, who are ready to hit the job market, now find positions hard to find or internships have been postponed or canceled. The jump to the “real world” is typically full of anxiety and uncertainty for seniors — and this year is no different with COVID-19 unsettling the job market.

We didn’t do it, says first U.S. hand sanitizer maker accused of false claims to treat, cure COVID-19

An Iowa-based hand sanitizer manufacturer the Food and Drug Administration cited in April for saying its products could “mitigate, prevent, treat, diagnose, or cure COVID-19” says the federal agency is wrong. An attorney for Prefense LLC, of Muscatine, also said the company told the FDA that before the agency announced its April 23 complaint against the firm on April 27, and that the FDA hasn’t acknowledged that response.